January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Pinetree Therapeutics, Inc.
Pinetree Therapeutics is a biotechnology company developing bispecific antibody-based targeted protein degraders through its proprietary AbReptor™ platform to address drug resistance and prevent tumor recurrence.